News and Press Releases
Why rare disease day is so important – Julie Matthews, CEO at TMC Pharma
Because each individual rare or orphan disease has such a low public profile, advocacy for research funding depends on a collective effort through channels such as Rare Disease Day. Whilst...
Category: Drug Discovery
Posted: February 28, 2024
Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK
Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer’s disease transgenic model to be presented at AD/PD 2024 Conference
Galimedix’s novel, orally administered small molecule offers the hope of changing the course of disease by targeting amyloid beta oligomers and protofibrils 28 February 2024 -- Maryland, US -- Galimedix...
Category: Biotechnology
Posted: February 28, 2024
Oxford-Harrington Rare Disease Centre to Hold Webinar Entitled ‘Pioneering a Path to Rare Disease Therapeutics’
OHC’s 4th Rare Disease Day webinar to be held on 28 February 2024, 3:00-4:00pm GMT 27 February 2024 – Oxford, UK and Cleveland, OH, US – The Oxford-Harrington Rare Disease...
Category: Drug Discovery
Posted: February 28, 2024
Department of Paediatrics, University of Oxford Level 2, John Radcliffe Hospital Oxford, OX3 9DU, UK
Capricorn Scientific and ExcellGene Form Strategic Partnership to Support Biotech Industries
Capricorn Scientific GmbH and ExcellGene SA form a cooperation to support the biotechnology sector with their united expertise Through their combined capabilities, Capricorn Scientific and ExcellGene enhance processes, develop advanced...
Category: Biotechnology
Posted: February 28, 2024
The Race For Answers: How Radboud University Medical Center Is Reducing The Time It Takes To Identify Rare Diseases
26 February 2024 – Nijmegen, the Netherlands – According to the United States’ National Institute of Health, an estimated 7,000 rare diseases collectively impact between 3.5% to 5.9% of the...
Category: Drug Discovery
Posted: February 27, 2024
University of Edinburgh acknowledges Pelago Patent and Use Of CETSA process
27 February 2024 – Stockholm, Sweden – Life Science Newswire – University of Edinburgh, UK, acknowledges Pelago Bioscience’s CETSA patent and use thereof in selected works in drug discovery research....
Category: Drug Discovery
Posted: February 27, 2024
Positive Results from Phase 3 Clinical Trial of Digital Therapeutic App SDT-001 and Submission for Marketing Approval in Japan
26 February 2024 -- Osaka, Japan -- Shionogi & Co announces the submission of a marketing approval application for the digital therapeutic app SDT-001, for commercialisation and sale in Japan,...
Category: Clinical Trials
Posted: February 27, 2024
Sequani invests in industry leading facilities as it eyes future growth
26 February 2024 -- Ledbury, UK -- As part of their strategic plans for growth and to meet the evolving needs of modern product developers, Ledbury-based contract research organisation (CRO)...
Category: Drug Discovery
Posted: February 27, 2024
SGD Pharma awarded 2024 gold EcoVadis rating in recognition of its commitment to sustainability
26 February 2024 -- Paris La Défense, France -- SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon...
Category: Manufacturing and Packing
Posted: February 26, 2024
Janssen Receives Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel; cilta-cel) for Treatment in Earlier Lines of Relapsed and Refractory Multiple Myeloma
Results from the phase 3 CARTITUDE-4 study, which supported the CHMP recommendation, showed that cilta-cel has the potential to offer significant benefit to patients in earlier lines of treatment Most...
Category: Clinical Trials
Posted: February 23, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
FGK Clinical Research GmbH Acquires Clinicology Ltd, Expanding Territorial Footprint in Europe
22 February 2024 -- Munich, Germany -- FGK Clinical Research GmbH, a European-based full-service provider of clinical research services, is thrilled to announce the successful acquisition of Clinicology Ltd, a...
Category: Clinical Trials
Posted: February 22, 2024
Aotearoa Clinical Trials Becomes First Site in New Zealand to Achieve both GCSA Certification and Silver Workforce Quality Accreditation
Certifications demonstrate Aotearoa Clinical Trials is working to the highest global best-practice standards, ratified by the industry 21 February 2024 -- Auckland, New Zealand and Maidenhead, UK -- Aotearoa Clinical Trials...
Category: Clinical Trials
Posted: February 21, 2024
Esme Green Building Middlemore Hospital 100 Hospital Rd Papatoetoe, 2025 Auckland, New Zealand
Kite Presents New Data for Yescarta (axicabtagene ciloleucel) CAR T-cell Therapy Highlighting Manufacturing Excellence and Cost-Effectiveness in the US
Data Highlights Industry-leading Manufacturing Success Rates for US Axicabtagene Ciloleucel Patients from Launch to Present Data Also Supports Cost-effectiveness of Axicabtagene Ciloleucel Versus Bispecific Antibodies 16 February 2024 – Stockley...
Category: BioManufacturing
Posted: February 21, 2024
Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park
20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...
Category: Manufacturing and Packing
Posted: February 20, 2024
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US
Principal IRB Becomes Univo IRB With Support From QHP Capital
20 February 2024 -- North Carolina -- Today, Univo IRB was announced as the new company name for Principal IRB. Univo IRB is a next generation institutional review board (IRB) recently acquired...
Category: Clinical Trials
Posted: February 20, 2024
